Hayden Michael R — SEC insider filings
SEC reporting owner CIK 1352908. 42 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2020-10-19 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 15 legs across 10 filings — 356,453 shares, $5,743,768 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 100,000 shares, $2,550,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 86.
- Largest priced transaction: sale of 100,000 shares @ $25.50 ($2,550,000) in AbCellera Biologics Inc., filed 2021-06-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Director | 13 | 5 legs · 223,665 sh · $2,799,976 | 1 leg · 100,000 sh · $2,550,000 | 15 |
| IONIS PHARMACEUTICALS INC (IONS) | Director | 17 | 6 legs · 45,000 sh · $1,865,879 | — | 32 |
| 89bio, Inc. (ETNB) | Director | 8 | 4 legs · 87,788 sh · $1,077,914 | — | 24 |
| Xenon Pharmaceuticals Inc. (XENE) | Director | 3 | — | — | 9 |
| Aurinia Pharmaceuticals Inc. (AUPH) | Director | 1 | — | — | 6 |
Insider filings — Hayden Michael R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Purchase (P): 5,000 @ $29.64 | EDGAR |
| 2026-08-24 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 53,613 @ $10.64 | EDGAR |
| 2026-08-14 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 46,387 @ $10.37 | EDGAR |
| 2026-08-13 | 4 | AbCellera Biologics Inc. (ABCL) | Gift (G): 50,000 @ $0 | EDGAR |
| 2026-07-31 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Purchase (P): 15,000 @ $53.38 · Purchase (P): 5,000 @ $51.60 | EDGAR |
| 2026-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | 89bio, Inc. (ETNB) | Code (U): 80,904 · Code (U): 103,978 · Code (U): 61,538 · Disposition to issuer (D): 27,647 (derivative) @ $0 · Disposition to issuer (D): 2,933 (derivative) @ $0 · Disposition to issuer (D): 22,730 (derivative) @ $0 · +7 more | EDGAR |
| 2025-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Purchase (P): 15,000 @ $31.86 | EDGAR |
| 2025-02-05 | 4 | 89bio, Inc. (ETNB) | Grant/award (A): 56,400 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Purchase (P): 2,500 @ $36.20 · Purchase (P): 2,500 @ $36.23 | EDGAR |
| 2024-07-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,111 (derivative) @ $0 · Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | 89bio, Inc. (ETNB) | Grant/award (A): 45,150 (derivative) @ $0 | EDGAR |
| 2023-09-26 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 20,000 @ $4.91 | EDGAR |
| 2023-08-09 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 30,000 @ $5.90 | EDGAR |
| 2023-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,777 @ $0 · Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,777 (derivative) @ $0 · Option exercise (M): 5,333 (derivative) @ $0 | EDGAR |
| 2023-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,321 (derivative) @ $0 · Grant/award (A): 4,677 (derivative) @ $0 | EDGAR |
| 2023-03-30 | 4 | 89bio, Inc. (ETNB) | Purchase (P): 6,250 @ $3.62 · Purchase (P): 10,000 @ $3.48 · Purchase (P): 10,000 @ $2.67 · Purchase (P): 61,538 @ $16.15 | EDGAR |
| 2023-02-13 | 4 | 89bio, Inc. (ETNB) | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 47,231 (derivative) @ $0 | EDGAR |
| 2022-10-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,777 @ $0 · Option exercise (M): 1,777 (derivative) @ $0 | EDGAR |
| 2022-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,777 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 1,777 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | 89bio, Inc. (ETNB) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 34,282 (derivative) @ $0 · Grant/award (A): 45,532 (derivative) @ $0 | EDGAR |
| 2021-10-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,777 @ $0 · Option exercise (M): 1,777 (derivative) @ $0 | EDGAR |
| 2021-09-15 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 270,000 @ $17.73 · Option exercise (M): 270,000 (derivative) @ $0 | EDGAR |
| 2021-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,778 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 1,778 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | AbCellera Biologics Inc. (ABCL) | Sale (S): 100,000 @ $25.50 | EDGAR |
| 2021-06-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 3,500 @ $3.85 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | 89bio, Inc. (ETNB) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-02-25 | 4 | 89bio, Inc. (ETNB) | Option exercise (M): 60,820 @ $1.93 · Option exercise (M): 6,447 @ $1.93 · Option exercise (M): 13,637 @ $3.11 · Option exercise (M): 60,820 (derivative) @ $0 · Option exercise (M): 6,447 (derivative) @ $0 · Option exercise (M): 13,637 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 5,144 @ $2.68 · Option exercise (M): 10,288 @ $3.67 · Option exercise (M): 30,864 @ $2.68 · Option exercise (M): 5,144 (derivative) @ $0 · Option exercise (M): 10,288 (derivative) @ $0 · Option exercise (M): 30,864 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Option exercise (M): 50,000 @ $5.44 · Option exercise (M): 30,000 @ $6.06 · Option exercise (M): 15,000 @ $6.42 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2020-12-17 | 4 | AbCellera Biologics Inc. (ABCL) | Option exercise (M): 270,000 @ $0.33 · Conversion (C): 117,647 · Purchase (P): 73,665 @ $20 · Option exercise (M): 270,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A) @ $2,000,000 · +1 more | EDGAR |
| 2020-10-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,778 @ $0 · Option exercise (M): 1,778 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1352908 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs